Matungala-Pafubel Mathy, Bulabula-Penge Junior, Matondo-Kuamfumu Meris, Esala Samy, Edidi-Atani François, Pukuta-Simbu Elisabeth, Tshiminyi-Munkamba Paul, Tutu Tshia N'kasar Yannick, Katanga Trésor, Ndomba-Mukanya Etienne, Mbonga-Mande Delphine, Baketana-Kinzonzi Lionel, Kinganda-Lusamaki Eddy, Mukadi-Bamuleka Daniel, Mambu-Mbika Fabrice, Mbala-Kingebeni Placide, Nkwembe-Ngabana Edith, Nkuba-Ndaye Antoine, Okitundu-Luwa Daniel, Ahuka-Mundeke Steve
Département de Virologie, Institut National de Recherche Biomédicale, Kinshasa 01204, Democratic Republic of the Congo.
Service de Microbiologie, Département de Biologie Médicale, Cliniques Universitaires de Kinshasa, Université de Kinshasa, Kinshasa H8P3+7X3, Democratic Republic of the Congo.
Pathogens. 2024 Feb 23;13(3):198. doi: 10.3390/pathogens13030198.
Polio-associated paralysis is one of the diseases under national surveillance in the Democratic Republic of the Congo (DRC). Although it has become relatively rare due to control measures, non-polio paralysis cases are still reported and constitute a real problem, especially for etiological diagnosis, which is necessary for better management and response. From September 2022 to April 2023, we investigated acute flaccid paralysis (AFP) cases in Kinshasa following an alert from the Provincial Division of Health. All suspected cases and their close contacts were investigated and sampled. Among the 57 sampled patients, 21 (36.8%) were suspects, and 36 (63.2%) were contacts. We performed several etiological tests available in the laboratory, targeting viruses, including Poliovirus, Influenza virus, SARS-CoV-2, Enterovirus, and arboviruses. No virus material was detected, but the serological test (ELISA) detected antibodies against Chikungunya Virus, i.e., 47.4% (27/57) for IgM and 22.8% (13/57) for IgG. Among suspected cases, we detected 33.3% (7/21) with anti-Chikungunya IgM and 14.3% (3/21) of anti-Chikungunya IgG. These results highlight the importance of enhancing the epidemiological surveillance of Chikungunya.
脊髓灰质炎相关麻痹是刚果民主共和国国家监测的疾病之一。尽管由于防控措施其已相对罕见,但非脊髓灰质炎麻痹病例仍有报告,且构成了一个实际问题,特别是对于病因诊断而言,病因诊断对于更好的管理和应对是必要的。2022年9月至2023年4月,在接到省级卫生部门的警报后,我们对金沙萨的急性弛缓性麻痹(AFP)病例进行了调查。对所有疑似病例及其密切接触者进行了调查和采样。在57例采样患者中,21例(36.8%)为疑似病例,36例(63.2%)为接触者。我们在实验室进行了多项针对包括脊髓灰质炎病毒、流感病毒、SARS-CoV-2、肠道病毒和虫媒病毒在内的病毒的病因学检测。未检测到病毒物质,但血清学检测(ELISA)检测到了针对基孔肯雅病毒的抗体,即IgM为47.4%(27/57),IgG为22.8%(13/57)。在疑似病例中,我们检测到33.3%(7/21)的抗基孔肯雅IgM和14.3%(3/21)的抗基孔肯雅IgG。这些结果凸显了加强基孔肯雅热流行病学监测的重要性。